Chapter 1. CAR-T Cell Therapy Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
 
Chapter 2. CAR-T Cell Therapy Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
            2.2.1    Demand Side
            2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
 
Chapter 3. CAR-T Cell Therapy Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
 
Chapter 4. CAR-T Cell Therapy Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
            4.5.1    Bargaining Power of Suppliers
            4.5.2    Bargaining Powers of Customers
            4.5.3    Threat of New Entrants
            4.5.4    Rivalry among Existing Players
            4.5.5    Threat of Substitutes
 
Chapter 5. CAR-T Cell Therapy Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
 
Chapter 6. CAR-T Cell Therapy Market – By Drug Type
6.1    Introduction/Key Findings   
6.2    Axicabtagene Ciloleucel  
6.3    Tisagenlecleucel
6.4    Brexucabtagene Autoleucel
6.5    Others

6.6    Y-O-Y Growth trend Analysis By Drug Type
6.7    Absolute $ Opportunity Analysis By Drug Type, 2024-2030
 
Chapter 7. CAR-T Cell Therapy Market – By Indication
7.1    Introduction/Key Findings   
7.2    Lymphoma  
7.3    Acute Lymphocytic Leukemia 
7.4    Others
7.5    Y-O-Y Growth  trend Analysis By Indication
7.6    Absolute $ Opportunity Analysis By Indication, 2024-2030
 
Chapter 8. CAR-T Cell Therapy Market –  By Distribution Channel
8.1    Introduction/Key Findings   
8.2    Hospitals
8.3    Cancer Treatment Centers
8.4    Pharmacy
8.5    Y-O-Y Growth trend Analysis By Distribution Channel
8.6    Absolute $ Opportunity Analysis By Distribution Channel, 2024-2030
 
Chapter 9. CAR-T Cell Therapy Market , By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
            9.1.1    By Country
                        9.1.1.1    U.S.A.
                        9.1.1.2    Canada
                        9.1.1.3    Mexico
            9.1.2    By Drug Type
            9.1.3    By Indication
            9.1.4    By By Distribution Channel
            9.1.5    Countries & Segments - Market Attractiveness Analysis
9.2    Europe
            9.2.1    By Country
                        9.2.1.1    U.K
                        9.2.1.2    Germany
                        9.2.1.3    France
                        9.2.1.4    Italy
                        9.2.1.5    Spain
                        9.2.1.6    Rest of Europe
            9.2.2    By Drug Type
            9.2.3    By Indication
            9.2.4    By Distribution Channel
            9.2.5    Countries & Segments - Market Attractiveness Analysis
9.3    Asia Pacific
            9.3.1    By Country
                        9.3.1.1    China
                        9.3.1.2    Japan
                        9.3.1.3    South Korea
                        9.3.1.4    India      
                        9.3.1.5    Australia & New Zealand
                        9.3.1.6    Rest of Asia-Pacific
            9.3.2    By Drug Type
            9.3.3    By Indication
            9.3.4    By Distribution Channel
            9.3.5    Countries & Segments - Market Attractiveness Analysis
9.4    South America
            9.4.1    By Country
                        9.4.1.1    Brazil
                        9.4.1.2    Argentina
                        9.4.1.3    Colombia
                        9.4.1.4    Chile
                        9.4.1.5    Rest of South America
            9.4.2    By Drug Type
            9.4.3    By Indication
            9.4.4    By Distribution Channel
            9.4.5    Countries & Segments - Market Attractiveness Analysis
9.5    Middle East & Africa
            9.5.1    By Country
                        9.5.1.1    United Arab Emirates (UAE)
                        9.5.1.2    Saudi Arabia
                       9.5.1.3    Qatar
                        9.5.1.4    Israel
                        9.5.1.5    South Africa
                        9.5.1.6    Nigeria
                        9.5.1.7    Kenya
                        9.5.1.8    Egypt
                        9.5.1.9    Rest of MEA
            9.5.2    By Drug Type
            9.5.3    By Indication
            9.5.4    By Distribution Channel
            9.5.5    Countries & Segments - Market Attractiveness Analysis
 
Chapter 10. CAR-T Cell Therapy Market – Company Profiles – (Overview, Drug Type Portfolio, Financials, Strategies & Developments)
10.1    Novozymes (Denmark)
10.2    DSM (Netherlands)
10.3    Chr. Hansen (Denmark)
10.4    Amano Enzymes (Japan)
10.5    Associated British Foods (UK)
10.6    DowDuPont (US)
10.7    Advanced Enzymes (India)
10.8    Enzyme Development Corporation (US)
10.9    Aumgene Biosciences (India)
10.10    Biocatalysts (UK)